Hitting an Elusive Target in Pancreatic Cancer - NCI
Targeting KRAS mutant cancers: from druggable therapy to drug resistance | Molecular Cancer | Full Text
Frontiers | New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness
IJMS | Free Full-Text | KRAS-Mutant Non-Small-Cell Lung Cancer: From Past Efforts to Future Challenges
KRAS-mutant non-small cell lung cancer: Converging small molecules and immune checkpoint inhibition - eBioMedicine
IJMS | Free Full-Text | Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
Cancers | Free Full-Text | Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
Frontiers | Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
The Trouble With KRAS - Cancer Commons
KRAS Mutations as Prognostic and Predictive Markers in Non–Small Cell Lung Cancer - ScienceDirect
Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pancreatic cancer | Scientific Reports
KRAS mutation A treatment target
A): Dynamic change in tumor marker (CA125) (blue line) and KRAS G12V... | Download Scientific Diagram
Computational Analysis of KRAS Mutations: Implications for Different Effects on the KRAS p.G12D and p.G13D Mutations | PLOS ONE
Cells | Free Full-Text | KRAS-Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions
Combination of KRAS gene silencing and PI3K inhibition for ovarian cancer treatment - ScienceDirect
KRAS drives immune evasion in a genetic model of pancreatic cancer | Nature Communications
Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations | Journal of Proteome Research
Frontiers | Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
Cureus | KRAS/NRAS/BRAF Mutation Rate in Saudi Academic Hospital Patients With Colorectal Cancer | Article
KRAS(G12D) can be targeted by potent inhibitors via formation of salt bridge | Cell Discovery
The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect
